Humana Inc. (NYSE:HUM) Shares Sold by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. trimmed its position in shares of Humana Inc. (NYSE:HUM) by 84.1% in the fourth quarter, HoldingsChannel reports. The firm owned 3,028 shares of the insurance provider’s stock after selling 15,987 shares during the period. Jefferies Financial Group Inc.’s holdings in Humana were worth $768,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Pinnacle Wealth Management Advisory Group LLC boosted its stake in Humana by 3.6% during the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares during the period. Mather Group LLC. boosted its stake in Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares during the period. Capital Advisors Ltd. LLC boosted its stake in Humana by 26.1% during the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 43 shares during the period. Retirement Planning Co of New England Inc. boosted its stake in Humana by 4.7% during the 4th quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock valued at $245,000 after purchasing an additional 43 shares during the period. Finally, LFA Lugano Financial Advisors SA boosted its stake in Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Guggenheim assumed coverage on shares of Humana in a research report on Wednesday, April 9th. They set a “buy” rating and a $326.00 price target on the stock. Raymond James upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research report on Thursday, May 1st. Morgan Stanley dropped their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price target on shares of Humana in a research report on Thursday, May 1st. Finally, Oppenheimer boosted their price target on shares of Humana from $300.00 to $310.00 and gave the stock an “outperform” rating in a research report on Thursday, May 1st. Seventeen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $286.81.

Humana Stock Down 1.8%

NYSE HUM opened at $226.26 on Friday. The company’s 50 day simple moving average is $263.20 and its 200 day simple moving average is $269.61. The company has a market capitalization of $27.31 billion, a P/E ratio of 22.74, a PEG ratio of 2.05 and a beta of 0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 12 month low of $212.45 and a 12 month high of $406.46.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the firm posted $7.23 earnings per share. Equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend is Friday, June 27th. Humana’s dividend payout ratio (DPR) is currently 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.